Ulkus Tropikum

01Pathophysiology

Tropical ulcer develops as a result of synergistic polymicrobial infection involving two principal organisms: Fusobacterium ulcerans, an obligate anaerobe, and Treponema vincentii, a spirochete. This is the same fusospirochetal pair responsible for Vincent angina (trench mouth) in the oral cavity, but in this case the process affects the skin and subcutaneous tissue.

The sequence begins with minor trauma to the lower extremity, often in someone walking barefoot in a tropical environment. The break in the skin barrier allows colonization by environmental bacteria. In a well-nourished host with intact immunity, these organisms are typically cleared. However, in the setting of protein-calorie malnutrition and vitamin deficiency (particularly vitamins A and C), the host immune response is compromised. This creates a permissive environment for the anaerobic-spirochetal partnership to establish itself.

Fusobacterium produces proteolytic enzymes and endotoxins that cause tissue necrosis and create an anaerobic microenvironment. This favors further anaerobic growth and deepening of the wound. Treponema vincentii acts synergistically by damaging the microvasculature and promoting local tissue ischemia, which accelerates necrosis. The result is a rapidly progressive, full-thickness ulceration with destruction of dermis, subcutaneous fat, and sometimes deeper structures including fascia, tendons, and periosteum.

The reason the lesion is almost always located on the anterior tibial region (the shin) is that this area has minimal subcutaneous fat, the skin is taut against bone, and blood supply is relatively poor. Once necrosis begins, healing capacity in this region is limited, which explains the tendency for chronicity.

In chronic cases persisting for months to years, the wound margins undergo repeated cycles of inflammation, fibrosis, and epithelial regeneration. This chronic irritative state creates a risk for malignant transformation into squamous cell carcinoma, a phenomenon known as a Marjolin ulcer. This is why any tropical ulcer that fails to heal despite adequate treatment, or that shows raised, rolled, or irregular edges, must be biopsied.

02Classification and Clinical Manifestation

Tropical ulcer progresses through three recognized phases. This classification is clinically important because management differs at each stage.

Additional clinical features by depth of involvement:

03Diagnostic Workup

The diagnosis of tropical ulcer is predominantly clinical. A classic vignette will describe a malnourished child or young adult from a tropical region presenting with a painful, foul-smelling, rapidly progressive ulcer on the lower leg, typically the shin. In this context, the best initial step is a thorough clinical examination combined with a Gram stain of wound discharge, which will demonstrate the characteristic fusiform bacilli and spirochetes.

Anaerobic culture can confirm the organism but takes time and is not always necessary in a straightforward clinical presentation. The culture becomes more important when the clinical picture is ambiguous or when the ulcer fails to respond to empiric therapy.

The most critical diagnostic step in the chronic phase is a tissue biopsy from the ulcer edge. Any ulcer that has been present for more than several weeks and shows no signs of healing, or one that develops raised, everted, or irregular margins, must be biopsied to exclude Marjolin ulcer (squamous cell carcinoma arising in a chronic wound). This is a high-yield concept: the question will describe a long-standing tropical ulcer with new changes at the wound edge, and the correct next step is biopsy, not more antibiotics.

Radiographic imaging is indicated when the ulcer overlies bone, particularly the anterior tibia, and there is clinical suspicion for periostitis or osteomyelitis (localized bone tenderness, swelling, failure to respond to soft-tissue management alone).

04Management and Treatment

Acute management centers on two pillars: antibiotics and local wound care.

Metronidazole is the cornerstone antibiotic because the primary pathogen, Fusobacterium ulcerans, is an obligate anaerobe exquisitely sensitive to metronidazole. The standard dose is 400 mg orally three times daily for 7 to 14 days. If the spirochetal component is prominent (dark-field examination or Gram stain showing abundant spirochetes), penicillin is added. Penicillin V at 500 mg four times daily for 7 to 10 days is the typical regimen. For patients with penicillin allergy, doxycycline (100 mg twice daily) or erythromycin (500 mg four times daily) can be substituted.

Wound care is equally important. The necrotic slough must be debrided to expose viable tissue and reduce the anaerobic bacterial burden. Daily cleaning with normal saline, followed by application of a moist wound dressing, promotes granulation tissue formation. Avoid occlusive dressings that trap anaerobic organisms.

Nutritional support is not optional. Tropical ulcer occurs in the setting of malnutrition, and healing will not occur without correcting the underlying nutritional deficit. High-protein supplementation, along with vitamin C (at least 500 mg daily), zinc, and iron, should be part of the treatment plan.

For chronic non-healing ulcers with a clean, granulating base, split-thickness skin grafting is the treatment of choice. However, before any graft is placed, a biopsy of the ulcer edge must be performed to rule out malignant transformation. If squamous cell carcinoma is confirmed, management shifts to wide local excision with or without lymph node evaluation, and grafting is deferred until margins are clear.

Contraindications and cautions: Metronidazole should be used with caution in patients taking alcohol (disulfiram-like reaction) and those with hepatic impairment. In pregnant patients, metronidazole is generally avoided in the first trimester. Penicillin remains safe in pregnancy and would be the preferred agent if needed.

05Differential Diagnosis and Distractors

06Traps and High-Yield Pearls

The most common way students lose points on tropical ulcer questions is by confusing it with Buruli ulcer. Both occur in tropical regions, both affect the lower extremity, and both can have undermined edges. The critical discriminator is pain: tropical ulcer is painful (especially in the acute phase), while Buruli ulcer is characteristically painless. If the vignette describes a painless ulcer with undermined edges in a tropical patient, think Buruli ulcer and look for acid-fast bacilli. If the vignette emphasizes pain and foul-smelling discharge, think tropical ulcer and look for fusiform bacilli and spirochetes.

The second trap involves chronic tropical ulcers. When a vignette describes a non-healing ulcer that has been present for months and now shows raised, irregular, or everted edges, the test is not asking about wound care or antibiotics. It is asking about Marjolin ulcer (squamous cell carcinoma arising in a chronic wound). The correct next step is always biopsy of the ulcer margin, not more antibiotics, not a skin graft, and not observation. Students who select "continue antibiotics" or "plan for grafting" without first ruling out malignancy will get this wrong.

A third testing angle is the nutritional component. A question may describe a patient whose ulcer fails to heal despite appropriate antibiotics and wound care, and then reveal that the patient has a serum albumin of 1.8 g/dL. The correct answer here is nutritional rehabilitation, because wound healing cannot proceed in the setting of severe protein malnutrition regardless of how well the infection is treated.

The core competency being tested across tropical ulcer questions is the ability to recognize a fusospirochetal wound infection in the right epidemiologic context, to distinguish it from painless tropical ulcers (Buruli ulcer, leishmaniasis), and to identify when a chronic ulcer has undergone malignant transformation requiring tissue diagnosis before definitive management.